Cargando…
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models
BACKGROUND: Personalised medicine strategies may improve outcomes in pancreatic ductal adenocarcinoma (PDAC), but validation of predictive biomarkers is required. Having developed a clinical trial to assess the ATR inhibitor, AZD6738, in combination with gemcitabine (ATRi/gem), we investigated ATM l...
Autores principales: | Dunlop, Charles R., Wallez, Yann, Johnson, Timothy Isaac, Bernaldo de Quirós Fernández, Sandra, Durant, Stephen T., Cadogan, Elaine B., Lau, Alan, Richards, Frances M., Jodrell, Duncan I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591912/ https://www.ncbi.nlm.nih.gov/pubmed/32741974 http://dx.doi.org/10.1038/s41416-020-1016-2 |
Ejemplares similares
-
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach
por: Johnson, Timothy I., et al.
Publicado: (2021) -
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma: ATM, ATR and FA in lung carcinoma
por: Beumer, Jan H., et al.
Publicado: (2015) -
Versatility of the Mec1(ATM/ATR) signaling network in mediating resistance to replication, genotoxic, and proteotoxic stresses
por: Corcoles-Saez, Isaac, et al.
Publicado: (2019) -
ATM and ATR Activities Maintain Replication Fork Integrity during SV40 Chromatin Replication
por: Sowd, Gregory A., et al.
Publicado: (2013) -
"ATR activation in response to ionizing radiation: still ATM territory"
por: Cuadrado, Myriam, et al.
Publicado: (2006)